Table 2.
Univariate and multivariable regression analyses of the radiomics score and clinical factors in the training cohort.
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| β | OR (95% CI) | P value | β | OR (95% CI) | P value | |
| Sex: Men vs women | 0.514 | 1.671 (0.565–4.958) | 0.354 | – | – | – |
| Age (continuous), year | −0.015 | 0.985 (0.956–1.016) | 0.351 | – | – | – |
| MRI-determined number of tumors, number | −0.095 | 0.910 (0.782–1.058) | 0.220 | – | – | – |
| MRI-determined tumor size (continuous), cm | 0.678 | 1.970 (1.479–2.625) | <0.001 | – | – | – |
| VI-RADS score | 2.295 | 9.920 (4.566–21.553) | <0.001 | 1.796 | 6.025 (2.417–15.022) | <0.001 |
| Radiomics score | 1.756 | 5.788 (3.115–10.754) | <0.001 | 1.385 | 3.996 (1.824–8.756) | 0.001 |
OR, odds ratio; MRI, magnetic resonance imaging; VI-RADS, Vesical Imaging-Reporting and Data System.